低磁热血症在服用质子抑制剂的患者中引起:一个病例报告
Takanobu Sato1, Ryogo Ohashi1, Katsuya Konishi1
1Division of Emergency Medicine, Department of Internal Medicine, Toho University Sakura Medical Center, Sakura, JPN.
Cureus
|February 3, 2025
概括
长期使用质子抑制剂 (PPI) 可能导致低磁血,导致其他电解质问题. 监测水平至关重要,因为在停止服用PPI后,正常化需要数周时间.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 长期使用质子抑制剂 (PPI) 与低磁性血症有关.
- 肠道中的吸收受损是主要的机制.
- 磁性低血症可能导致二次电解质障碍,如低血和低血症.
研究的目的:
- 要突出一个与PPI使用相关的多个电解质异常的案例.
- 强调监测PPI患者血清水平的重要性.
- 讨论PPI停止后水平延迟正常化的情况.
主要方法:
- 案例报告的呈现方式.
- 对与PPI治疗相关的电解质失衡的审查.
- 讨论诊断和管理策略.
主要成果:
- 质子抑制剂诱导的低磁性血症可能导致复杂的电解质干扰.
- 在停止PPI后,血清度可能需要几个星期才能正常化.
- 重复测量血清是必要的门诊管理.
结论:
- 由PPI诱导的低血症需要对血清水平进行警监测.
- 延迟的正常化强调了需要长时间的随访.
- 早期停止使用PPI和补充是关键的管理策略.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Antiepileptic Drugs: GABAergic Pathway Potentiators
316
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
316
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
350
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
350
Antiepileptic Drugs: Glutamate Antagonists
271
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
271
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
318
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
318
Antiepileptic Drugs: Calcium Channel Blockers
297
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
297


